Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 7,800 | 8,285 | 6,888 | 10,860 | 19,289 |
| Operating Income | -7,800 | -8,285 | -6,888 | -10,860 | -19,289 |
| Other Income | -178 | -4,913 | -114 | 63 | -229 |
| Pre-tax Income | -7,977 | -13,198 | -7,002 | -10,796 | -19,517 |
| Income Tax | N/A | N/A | N/A | N/A | -94 |
| Net Income Continuous | -7,977 | -13,198 | -7,002 | -10,796 | -19,423 |
| Net Income Discontinuous | N/A | N/A | 1,879 | -1,935 | N/A |
| Net Income | $-7,977 | $-13,198 | $-5,123 | $-12,731 | $-19,423 |
| EPS Basic Total Ops | -11.93 | -68.01 | -90.00 | -317.75 | -650.00 |
| EPS Basic Continuous Ops | -11.93 | -68.01 | -122.75 | -269.50 | -653.06 |
| EPS Basic Discontinuous Ops | N/A | N/A | -33.00 | -48.25 | N/A |
| EPS Diluted Total Ops | -11.93 | -68.01 | -90.00 | -317.75 | -650.00 |
| EPS Diluted Continuous Ops | -11.93 | -68.01 | -122.75 | -269.50 | -653.06 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -33.00 | -48.25 | N/A |
| EPS Diluted Before Non-Recurring Items | -11.93 | -45.00 | -122.75 | -318.75 | -650.00 |
| EBITDA(a) | $-7,799 | $-8,284 | $-6,887 | $-10,859 | $-19,234 |